Indian Pharma Lobby Calls For Re-examination Of 81 MNC Drug Patents
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - As Indian companies battle multinational drug giants for patent rights, the Indian Pharmaceutical Alliance - an association that represents top Indian drug companies - wrote to the Union Ministry of Commerce and Industry Feb. 14 that a large number of pharmaceutical patents granted over the last four years are granted to new forms of known substances and combinations of old drugs